Pharmaceutical Executive Europe - Pharma news, strategy, sales & marketing, R&D, M&A, regulation, technology
 Home   Log-in   Register   Subscribe / Renew   e-Alerts   About Us   Media Kit   Contact   RSS  

CORPORATE STRATEGY FINANCE, M&A R&D REGULATORY, LEGAL SALES & MARKETING SUPPLY CHAIN, TECHNOLOGY

You are logged in as
Username:
Password:
Remember me so that I do not have to log in the next time I visit
Survey
In light of the British Medical Journal's controversial article asserting that pharma KOLs are no more than glorified sales reps, do you think there should be more transparency in industry's dealings with influential doctors?
Yes
No
This warrants further investigation first
Yes
60%
No
17%
This warrants further investigation first
24%
View Results
Thank you for voting
Previous StoryPlay / PauseNext Story
News update
Grow Your Oncology Brand
Join IMS's Educational Oncology Market Webinars, 8–17 July.
27-June-08: New vaccination production plant opens in France
Sanofi Pasteur has opened a new €100 million vaccination production plant in Val de Reuil, France.
25-June-08: Bayer signs agreement with US generic company
Bayer AG has signed a supply and licensing agreement with the American generic drug manufacturer Barr Pharmaceuticals.
20-June-2008: Pfizer and Ranbaxy reach an agreement
A settlement between Pfizer and Ranbaxy means that the latter will be able to start selling its generic form of the cholesterol drug Lipitor by late 2011.
19-June-08: ThromboGenics and BioInvent strike a deal with Roche
ThromboGenics and BioInvent International have entered into a license agreement with Roche for their jointly developed anti-cancer agent TB-403.
Latest content from related sites...
Pharmaceutical Executive Magazine
Latest content from the Pharmaceutical Executive website:
Pharma CEOs Expound on Industry Change
New Educational Program to Boost PR Compliance
New Act to Protect Patients Could Cripple Preemption
State and Territorial Health Officials Take Critical Steps to Protect Vulnerable Populations; Association Releases Pandemic Preparedness Guidance
Zinc Finger Proteins Put Personalized HIV Therapy Within Reach; Penn Researchers Modify T-Cell Receptor Gene to Develop New Type of AIDS Treatment
Pharmaceutical Technology Europe
Latest content from the Pharmaceutical Technology Europe website:
Funding with wargames
Can microdosing help?
Summer is coming!
New interest in an old market: South Korea
Lluis Ribas de Pouplana
Latest issue
Click here to view the latest issue
Readership survey
Sales training
Sales Training for Real Behaviour Change
Beyond the blockbuster

What Can Big Pharma Learn from Mid-tier and Specialty Pharma?

Make This Page Your Home Page!
Click here